MTOR and colorectal carcinoma: The MAPK/ERK pathway (often deregulated by KRAS/BRAF mutations in CRC) converges on metabolic regulators via scaffolds like the LAMTOR/Ragulator complex at lysosomes, coordinating mTOR and MAPK activation.